Cargando…
Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid‐induced muscle cell atrophy
BACKGROUND: Many pathological states characterized by muscle atrophy are associated with an increase in circulating glucocorticoids and poor patient prognosis, making it an important target for treatment. The development of treatments for glucocorticoid‐induced and wasting disorder‐related skeletal...
Autores principales: | Cid‐Díaz, Tania, Santos‐Zas, Icía, González‐Sánchez, Jessica, Gurriarán‐Rodríguez, Uxía, Mosteiro, Carlos S., Casabiell, Xesús, García‐Caballero, Tomás, Mouly, Vincent, Pazos, Yolanda, Camiña, Jesús P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700440/ https://www.ncbi.nlm.nih.gov/pubmed/28675664 http://dx.doi.org/10.1002/jcsm.12222 |
Ejemplares similares
-
Obestatin controls skeletal muscle fiber-type determination
por: Santos-Zas, Icía, et al.
Publicado: (2017) -
Publisher Correction: Obestatin controls skeletal muscle fiber-type determination
por: Santos-Zas, Icía, et al.
Publicado: (2018) -
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
por: Cid‐Díaz, Tania, et al.
Publicado: (2021) -
Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment
por: González‐Sánchez, Jessica, et al.
Publicado: (2018) -
The NMR Structure of Human Obestatin in Membrane-Like Environments: Insights into the Structure-Bioactivity Relationship of Obestatin
por: Alén, Begoña O., et al.
Publicado: (2012)